These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9687175

  • 21. HPLC analysis of ammonium glycyrrhizate listed in the European, United States, and Japanese Pharmacopoeias under reported and modified conditions: revision of the peak assignment for 18α-glycyrrhizin in the European and United States Pharmacopoeias.
    Kamata K, Tatsuzaki J, Ishikawa T, Arai R, Hakamatsuka T, Uchiyama N.
    J Nat Med; 2023 Jan; 77(1):202-206. PubMed ID: 36066807
    [Abstract] [Full Text] [Related]

  • 22. The development of USP botanical dietary supplement monographs, 1995-2005.
    Schiff PL, Srinivasan VS, Giancaspro GI, Roll DB, Salguero J, Sharaf MH.
    J Nat Prod; 2006 Mar; 69(3):464-72. PubMed ID: 16562859
    [Abstract] [Full Text] [Related]

  • 23. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L, Dabbah R, Hauck W, Sheinin E, Yeoman L, Williams R.
    AAPS J; 2005 Nov 17; 7(4):E786-812. PubMed ID: 16594632
    [Abstract] [Full Text] [Related]

  • 24. USP monographs and tests of radiochemical purity.
    Briner WH.
    Am J Health Syst Pharm; 1995 Aug 15; 52(16):1817-8. PubMed ID: 8528842
    [No Abstract] [Full Text] [Related]

  • 25. The pharmacopeial perspective in accelerating the development and availability of biologicals and biotechnological-derived products.
    Williams RL.
    Dev Biol (Basel); 2002 Aug 15; 109():137-42. PubMed ID: 12434923
    [No Abstract] [Full Text] [Related]

  • 26. Monographs for medicines on WHO's Model List of Essential Medicines.
    Roth L, Adler M, Jain T, Bempong D.
    Bull World Health Organ; 2018 Jun 01; 96(6):378-385. PubMed ID: 29904220
    [Abstract] [Full Text] [Related]

  • 27. Parametric two-stage sequential quality assurance test of dose content uniformity.
    Tsong Y, Shen M.
    J Biopharm Stat; 2007 Jun 01; 17(1):143-57. PubMed ID: 17219760
    [Abstract] [Full Text] [Related]

  • 28. United States Pharmacopeia activities in the area of vaccines, virology and immunology.
    Morris TS.
    Vaccine; 2005 Mar 18; 23(17-18):2311-3. PubMed ID: 15755617
    [Abstract] [Full Text] [Related]

  • 29. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL, 2000-2005 Reference Standards Committee of the USP Council of Experts and Its Advisory Panel, USP Staff and Consultant.
    J Pharm Biomed Anal; 2006 Jan 23; 40(1):3-15. PubMed ID: 16303277
    [Abstract] [Full Text] [Related]

  • 30. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
    Tidswell EC, Tirumalai RS, Gross DD.
    PDA J Pharm Sci Technol; 2024 Jun 28; 78(3):348-357. PubMed ID: 38942475
    [Abstract] [Full Text] [Related]

  • 31. [On publishing of the Xth edition of the USSR state pharmacopoeia].
    Bushkova MN, Rapaport LI, Shakh TsI, Iampol'skaia MM.
    Farm Zh; 1967 Jun 28; 22(1):14-8. PubMed ID: 5600203
    [No Abstract] [Full Text] [Related]

  • 32. [Pharmacopeia and preparations for cutaneous application].
    Esnault F, Etchegaray JP, Mallard C.
    Ann Dermatol Venereol; 2007 Mar 28; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of temperature rise interpretations in the rabbit pyrogen test among Chinese, Japanese, European, and United States pharmacopeias and 2-2-2 theoretical models proposed by S. Hoffmann.
    Du Y, Li XJ, Tan DJ.
    Innate Immun; 2011 Oct 28; 17(5):486-95. PubMed ID: 21088045
    [Abstract] [Full Text] [Related]

  • 34. [On the project of the general chapter on "sterilization" in the 10th edition of the State Pharmacopoeia of the USSR].
    Bul'varova ZI, Nikitina LI, Maslennikova LS, Karchevskaia VV, Samsonova MN, Smolina ZV.
    Aptechn Delo; 1966 Oct 28; 15(5):13-8. PubMed ID: 6001287
    [No Abstract] [Full Text] [Related]

  • 35. The harmonization of the regulation of blood products: a European perspective.
    Seitz R, Heiden M, Nübling CM, Unger G, Löwer J.
    Vox Sang; 2008 May 28; 94(4):267-76. PubMed ID: 18179678
    [Abstract] [Full Text] [Related]

  • 36. Comparison of temperature rise interpretations between European and United States Pharmacopeias' pyrogen tests.
    Tschumi J.
    PDA J Pharm Sci Technol; 2003 May 28; 57(3):218-27. PubMed ID: 12877332
    [Abstract] [Full Text] [Related]

  • 37. [A proposal by the Japanese Pharmacopoeia for a method to set an endotoxin limit for parenteral drugs to be tested].
    Ogawa Y.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997 May 28; (115):210-2. PubMed ID: 9641849
    [Abstract] [Full Text] [Related]

  • 38. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
    Fischer L, Zipfel B, Koellensperger G, Kovac J, Bilz S, Kunkel A, Venzago C, Hann S.
    J Pharm Biomed Anal; 2014 Jul 28; 95():121-9. PubMed ID: 24667566
    [Abstract] [Full Text] [Related]

  • 39. Participation of industry experts in the elaboration of monographs and chapters of the European Pharmacopoeia.
    Rose U.
    Eur J Pharm Sci; 2016 Oct 10; 93():504-6. PubMed ID: 27131607
    [Abstract] [Full Text] [Related]

  • 40. [Anatomy of a pharmacopoeia. Comments on F.U. VII].
    Sciortino T.
    Boll Chim Farm; 1966 Sep 10; 105(9):644-59. PubMed ID: 5994024
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.